Eli Lilly (LLY) Dividends Paid - Common (2009 - 2026)
Eli Lilly (LLY) posted Dividends Paid - Common of $1.5 billion for Q1 2026, up 15.05% quarter-over-quarter from $1.3 billion in Q4 2025, and up 15.01% year-on-year from $1.3 billion in Q1 2025.
Eli Lilly (LLY) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Eli Lilly (LLY) has reported Dividends Paid - Common for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.
- Dividends Paid - Common for Q1 2026 came in at $1.5 billion, up 15.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 15.01% YoY), and the FY2025 annual result was $5.4 billion, up 15.04% from the prior year.
- Dividends Paid - Common was $1.5 billion for Q1 2026 at Eli Lilly, up from $1.3 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $2.0 billion in Q2 2023 and troughed at $882.2 million in Q3 2022.
- Average Dividends Paid - Common over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
- Year-over-year, Dividends Paid - Common slumped 42.36% in 2024 and gained 15.21% in 2025.
- Over 5 years, Dividends Paid - Common stood at $884.4 million in 2022, then advanced by 15.08% to $1.0 billion in 2023, then advanced by 14.75% to $1.2 billion in 2024, then advanced by 15.21% to $1.3 billion in 2025, then rose by 15.05% to $1.5 billion in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $1.5 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Bn |
| Mar 31, 2026 | 1.55 Bn |
| Dec 31, 2025 | 1.35 Bn |
| Dec 31, 2025 | 1.35 Bn |
| Sep 30, 2025 | 1.35 Bn |
| Sep 30, 2025 | 1.35 Bn |
| Jun 30, 2025 | 1.35 Bn |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.35 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.17 Bn |
| Mar 31, 2024 | 1.17 Bn |
| Mar 31, 2024 | 1.17 Bn |
| Dec 31, 2023 | 1.02 Bn |
| Dec 31, 2023 | 1.02 Bn |